Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome

American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome

(2018) Alexander C. Ford et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome

(2017) Julien Tap et al.   GASTROENTEROLOGY

A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial

(2017) Heidi Maria Staudacher et al.   GASTROENTEROLOGY

Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome

(2017) Maria Ines Pinto-Sanchez et al.   GASTROENTEROLOGY

A double-blind, placebo-controlled study to assess the effect of a probiotic mixture on symptoms and inflammatory markers in women with diarrhea-predominant IBS

(2017) K. Hod et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Irritable Bowel Syndrome

(2017) Alexander C. Ford et al.   NEW ENGLAND JOURNAL OF MEDICINE

A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth

(2016) Uday C. Ghoshal et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Efficacy of Lactobacillus casei Shirota for patients with irritable bowel syndrome

(2016) Annemieke Y. Thijssen et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome

(2016) Anthony Lembo et al.   GASTROENTEROLOGY

Bowel Disorders

(2016) Brian E. Lacy et al.   GASTROENTEROLOGY

Development and Validation of the Rome IV Diagnostic Questionnaire for Adults

(2016) Olafur S. Palsson et al.   GASTROENTEROLOGY

Effects of scFOS on the composition of fecal microbiota and anxiety in patients with irritable bowel syndrome: a randomized, double blind, placebo controlled study

(2016) F. Azpiroz et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Irritable bowel syndrome symptom severity improves equally with probiotic and placebo

(2016) Anna Lyra et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Effects of Rifaximin on Transit, Permeability, Fecal Microbiome and Organic Acid Excretion in Irritable Bowel Syndrome

(2016) Andrés Acosta et al.   Clinical and Translational Gastroenterology

A randomized clinical trial of Saccharomyces cerevisiae versus placebo in the irritable bowel syndrome

(2015) Guillaume Pineton de Chambrun et al.   DIGESTIVE AND LIVER DISEASE

Effect of administering a multi-species probiotic mixture on the changes in fecal microbiota and symptoms of irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial

(2015) Hyuk Yoon et al.   JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION

Randomized double blind placebo-controlled trial of Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipation

(2015) Robin Spiller et al.   United European Gastroenterology Journal

Lactobacillus acidophilusNCFM affects colonic mucosal opioid receptor expression in patients with functional abdominal pain - a randomised clinical study

(2014) T. Ringel-Kulka et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Randomised clinical trial: a liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome - a 12 week double-blind study

(2014) G. Sisson et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double-blind, placebo-controlled trials

(2014) P. Schoenfeld et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

American College of Gastroenterology Monograph on the Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation

(2014) Alexander C Ford et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Efficacy of Prebiotics, Probiotics and Synbiotics in Irritable Bowel Syndrome and Chronic Idiopathic Constipation: Systematic Review and Meta-analysis

(2014) Alexander C Ford et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Melatonin Regulation as a Possible Mechanism for Probiotic (VSL#3) in Irritable Bowel Syndrome: A Randomized Double-Blinded Placebo Study

(2014) Reuben K. Wong et al.   DIGESTIVE DISEASES AND SCIENCES

The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic

(2014) Colin Hill et al.   Nature Reviews Gastroenterology & Hepatology

Randomized clinical trial on the effect of a multispecies probiotic on visceroperception in hypersensitive IBS patients

(2014) S. Ludidi et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Randomized clinical trial: Effect of Lactobacillus plantarum 299 v on symptoms of irritable bowel syndrome

(2014) Cheryl Stevenson et al.   NUTRITION

I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life

(2014) Vicente Lorenzo-Zúñiga   WORLD JOURNAL OF GASTROENTEROLOGY

A randomised controlled trial of a probiotic ‘functional food’ in the management of irritable bowel syndrome

(2013) Lesley M Roberts et al.   BMC GASTROENTEROLOGY

Effect of Korean Herbal Medicine Combined with a Probiotic Mixture on Diarrhea-Dominant Irritable Bowel Syndrome: A Double-Blind, Randomized, Placebo-Controlled Trial

(2013) Seok-Jae Ko et al.   Evidence-based Complementary and Alternative Medicine

Instability of the faecal microbiota in diarrhoea-predominant irritable bowel syndrome

(2013) Ana Durbán et al.   FEMS MICROBIOLOGY ECOLOGY

Faecal microbiota composition and host–microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome

(2013) Jonna Jalanka-Tuovinen et al.   GUT

Effect of multispecies probiotics on irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial

(2013) Jun Sik Yoon et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Long-term treatment with probiotics in primary care patients with irritable bowel syndrome – a randomised, double-blind, placebo controlled trial

(2013) Luise Mølenberg Begtrup et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis

(2012) Rebecca M. Lovell et al.   Clinical Gastroenterology and Hepatology

Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome

(2012) I. M. Carroll et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Effect of composite yogurt enriched with acacia fiber andBifidobacterium lactis

(2012) Yang Won Min   WORLD JOURNAL OF GASTROENTEROLOGY

Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: A randomized, double-blind study

(2012) Michel Dapoigny   WORLD JOURNAL OF GASTROENTEROLOGY

Clinical trial:Lactobacillus plantarum299v (DSM 9843) improves symptoms of irritable bowel syndrome

(2012) Philippe Ducrotté   WORLD JOURNAL OF GASTROENTEROLOGY

Probiotics, Symptoms, and Gut Microbiota: What Are the Relations? A Randomized Controlled Trial in Subjects with Irritable Bowel Syndrome

(2012) Per G. Farup et al.   Gastroenterology Research and Practice

Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life -- a double-blind, placebo-controlled study

(2011) S. Guglielmetti et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota

(2011) Ian B Jeffery et al.   GUT

A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome

(2011) Wolfgang Kruis et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Probiotic Bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 Versus Placebo for the Symptoms of Bloating in Patients With Functional Bowel Disorders

(2011) Tamar Ringel-Kulka et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

A Randomized, Double-blind, Placebo-controlled Multicenter Trial of Saccharomyces boulardii in Irritable Bowel Syndrome

(2011) Chang Hwan Choi et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

The Effect of a Multispecies Probiotic Mixture on the Symptoms and Fecal Microbiota in Diarrhea-dominant Irritable Bowel Syndrome

(2011) Bong Ki Cha et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation

(2011) Mark Pimentel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: A randomized, placebo-controlled trial

(2011) Bo Søndergaard et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS

(2010) D. Yu et al.   GUT

Effect of Probiotics on Symptoms in Korean Adults with Irritable Bowel Syndrome

(2010) Kyoung Sup Hong et al.   Gut and Liver

Gut Microbiota is Not Modified by Randomized, Double-Blind, Placebo-Controlled Trial of VSL#3 in Diarrhea-Predominant Irritable Bowel Syndrome

(2010) Sonia Michail et al.   Probiotics and Antimicrobial Proteins

Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: Systematic Review and Meta-analysis

(2009) Alexander C. Ford et al.   Clinical Gastroenterology and Hepatology

Randomized Controlled Treatment Trial of Irritable Bowel Syndrome with a Probiotic E.-coli Preparation (DSM17252) Compared to Placebo

(2009) P Enck et al.   ZEITSCHRIFT FUR GASTROENTEROLOGIE

Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome

(2008) J. ZENG et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome

(2008) D. B. A. SILK et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study

(2008) E. A. WILLIAMS et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Clinical trial: the effects of a fermented milk product containingBifidobacterium lactisDN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation

(2008) A. AGRAWAL et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Irritable Bowel Syndrome: A 10-Yr Natural History of Symptoms and Factors That Influence Consultation Behavior

(2008) Alexander C. Ford et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Therapeutic Effect of Lactobacillus acidophilus-SDC 2012, 2013 in Patients with Irritable Bowel Syndrome

(2008) Dong Hyun Sinn et al.   DIGESTIVE DISEASES AND SCIENCES

A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome

(2008) S. Drouault-Holowacz et al.   GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE

The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review

(2008) P. Moayyedi et al.   GUT

A mixture ofEscherichia coli(DSM 17252) andEnterococcus faecalis(DSM 16440) for treatment of the irritable bowel syndrome - A randomized controlled trial with primary care physicians

(2008) p. enck et al.   NEUROGASTROENTEROLOGY AND MOTILITY